MAINZ BIOMED NV (MYNZ)

NL0015000LC2 - Common Stock

4.38  +0.08 (+1.86%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
895.48K530.00K580.00K490.00K280.00K
Cost Of Goods
385.82K350.00K400.00K370.00K340.00K
Gross Profit
509.66K180.00K180.00K120.00K-60.00K
Operating Expenses
27.15M26.69M9.90M800.00K860.00K
Research and Development
9.07M3.55M440.00K290.00K230.00K
Selling, General, and Administrative Expenses
17.22M22.88M9.40M450.00K580.00K
Operating Income
-26.64M-26.51M-9.72M-680.00K-920.00K
Interest Income/Expense
-809.58K-210.00K-200.00K-180.00K-160.00K
Other Income/Expense
1.10M330.00K250.00K260.00K120.00K
Non Recurring Items
55.28K0.00-2.02M10.00K0.00
Income Before Taxes
-26.30M-26.39M-11.69M-590.00K-960.00K
Net Income
-26.30M-26.39M-11.69M-590.00K-960.00K
EBITDA
-25.78M-26.13M-9.65M-620.00K-870.00K
 
Per Share Data
EPS Diluted Total Ops
-64.76-1.86-0.84-0.04-0.07
Non GAAP EPS
-1.64N/AN/AN/AN/A
 
Statistics
Gross Profit Margin
56.91%33.96%31.03%24.49%-21.43%
Profit Margin
-2936.50%-4979.25%-2015.52%-120.41%-342.86%
Operating Profit Margin
-2975.46%-5001.89%-1675.86%-138.78%-328.57%

All data in USD

Charts